Mercados españoles cerrados

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Precio demorado. Divisa en USD
Añadir a la lista de favoritos
421,93+3,38 (+0,81%)
Al cierre: 04:05PM EDT
421,93 +0,06 (+0,01%)
Después del cierre: 04:05PM EDT

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Sector(es)Healthcare
SectorMedical Devices
Empleados a tiempo completo7900

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Norman D. SchwartzChairman, CEO & Pres3,15M26,13M1950
Mr. Ilan DaskalExec. VP & CFO1,18M782,98k1966
Dr. Andrew J. Last Ph.D.Exec. VP & COO1,54M1,03M1960
Mr. Michael CrowleyExec. VP of Global Commercial Operations974,94k1,85M1962
Ms. Dara Grantham WrightExec. VP & Pres of Clinical Diagnostics Group1,06MN/A1976
Mr. Ajit RamalingamSr. VP & Chief Accounting OfficerN/AN/A1973
Mr. Yong ChungVP of Investor RelationsN/AN/AN/A
Mr. Timothy S. ErnstExec. VP, Gen. Counsel & Sec.N/AN/A1960
Colleen CoreySr. VP of Global HRN/AN/AN/A
Lee BoydSr. VP of Global Commercial Operations - Asia PacificN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Gobierno corporativo

El ISS Governance QualityScore de Bio-Rad Laboratories, Inc., a día 1 de septiembre de 2022, es 10. Las puntuaciones base son Auditoría: 10; Tablero: 10; Derechos de los accionistas: 10; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.